Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valery Radchenko

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Inorganic Chemistry|June 9, 2021
Tuning the Kinetic Inertness of Bi<sup>3+</sup> Complexes: The Impact of Donor Atoms on Diaza-18-Crown-6 Ligands as Chelators for <sup>213</sup>Bi Targeted Alpha TherapyDavid J Fiszbein, Victoria Brown, Nikki A Thiele, et al.
Bioconjugate Chemistry|March 29, 2020
<sup>225</sup>Ac-H<sub>4</sub>py4pa for Targeted Alpha TherapyLily Li, Julie Rousseau, María de Guadalupe Jaraquemada-Peláez, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 27, 2020
Synthesis and Evaluation of a Macrocyclic Actinium-225 Chelator, Quality Control and In Vivo Evaluation of <sup>225</sup> Ac-crown-αMSH PeptideHua Yang, Chengcheng Zhang, Zheliang Yuan, et al.
Nuclear Medicine and Biology|January 14, 2025
Alpha Atlas: Mapping global production of α-emitting radionuclides for targeted alpha therapyMarianna Tosato, Chiara Favaretto, Janke Kleynhans, et al.
Nuclear Medicine and Biology|July 7, 2022
An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT)Ayagoz Baimukhanova, Gokce Engudar, Genko Marinov, et al.
Dalton Transactions (Cambridge, England : 2003)|April 10, 2020
Coordination chemistry of [Y(pypa)]<sup>-</sup> and comparison immuno-PET imaging of [<sup>44</sup>Sc]Sc- and [<sup>86</sup>Y]Y-pypa-phenyl-TRC105Lily Li, María de Guadalupe Jaraquemada-Peláez, Eduardo Aluicio-Sarduy, et al.
Journal of Medicinal Chemistry|September 22, 2023
Rearmed Bifunctional Chelating Ligand for <sup>225</sup>Ac/<sup>155</sup>Tb Precision-Guided Theranostic Radiopharmaceuticals─H<sub>4</sub>noneunpaXLuke Wharton, Hua Yang, María de Guadalupe Jaraquemada-Peláez, et al.
Bioconjugate Chemistry|March 3, 2022
[<sup>213</sup>Bi]Bi<sup>3+</sup>/[<sup>111</sup>In]In<sup>3+</sup>-neunpa-cycMSH: Theranostic Radiopharmaceutical Targeting Melanoma─Structural, Radiochemical, and Biological EvaluationLuke Wharton, Chengcheng Zhang, Hua Yang, et al.
Journal of the American Chemical Society|June 30, 2021
Py-Macrodipa: A Janus Chelator Capable of Binding Medicinally Relevant Rare-Earth Radiometals of Disparate SizesAohan Hu, Eduardo Aluicio-Sarduy, Victoria Brown, et al.
Inorganic Chemistry|August 25, 2020
Perturbed Angular Correlation as a Tool to Study Precursors for RadiopharmaceuticalsElena S Kurakina, Valery Radchenko, Andrey N Belozub, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Inorganic Chemistry|June 9, 2021
Tuning the Kinetic Inertness of Bi<sup>3+</sup> Complexes: The Impact of Donor Atoms on Diaza-18-Crown-6 Ligands as Chelators for <sup>213</sup>Bi Targeted Alpha TherapyDavid J Fiszbein, Victoria Brown, Nikki A Thiele, et al.
Bioconjugate Chemistry|March 29, 2020
<sup>225</sup>Ac-H<sub>4</sub>py4pa for Targeted Alpha TherapyLily Li, Julie Rousseau, María de Guadalupe Jaraquemada-Peláez, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 27, 2020
Synthesis and Evaluation of a Macrocyclic Actinium-225 Chelator, Quality Control and In Vivo Evaluation of <sup>225</sup> Ac-crown-αMSH PeptideHua Yang, Chengcheng Zhang, Zheliang Yuan, et al.
Nuclear Medicine and Biology|January 14, 2025
Alpha Atlas: Mapping global production of α-emitting radionuclides for targeted alpha therapyMarianna Tosato, Chiara Favaretto, Janke Kleynhans, et al.
Nuclear Medicine and Biology|July 7, 2022
An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT)Ayagoz Baimukhanova, Gokce Engudar, Genko Marinov, et al.
Dalton Transactions (Cambridge, England : 2003)|April 10, 2020
Coordination chemistry of [Y(pypa)]<sup>-</sup> and comparison immuno-PET imaging of [<sup>44</sup>Sc]Sc- and [<sup>86</sup>Y]Y-pypa-phenyl-TRC105Lily Li, María de Guadalupe Jaraquemada-Peláez, Eduardo Aluicio-Sarduy, et al.
Journal of Medicinal Chemistry|September 22, 2023
Rearmed Bifunctional Chelating Ligand for <sup>225</sup>Ac/<sup>155</sup>Tb Precision-Guided Theranostic Radiopharmaceuticals─H<sub>4</sub>noneunpaXLuke Wharton, Hua Yang, María de Guadalupe Jaraquemada-Peláez, et al.
Bioconjugate Chemistry|March 3, 2022
[<sup>213</sup>Bi]Bi<sup>3+</sup>/[<sup>111</sup>In]In<sup>3+</sup>-neunpa-cycMSH: Theranostic Radiopharmaceutical Targeting Melanoma─Structural, Radiochemical, and Biological EvaluationLuke Wharton, Chengcheng Zhang, Hua Yang, et al.
Journal of the American Chemical Society|June 30, 2021
Py-Macrodipa: A Janus Chelator Capable of Binding Medicinally Relevant Rare-Earth Radiometals of Disparate SizesAohan Hu, Eduardo Aluicio-Sarduy, Victoria Brown, et al.
Inorganic Chemistry|August 25, 2020
Perturbed Angular Correlation as a Tool to Study Precursors for RadiopharmaceuticalsElena S Kurakina, Valery Radchenko, Andrey N Belozub, et al.
Pageof 8